During the past decade, National Institute of Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "National Institute of Oncology" are "Colorectal Cancer" (1 trials) and "Gastrointestinal Stromal Tumors" (1 trials). Many other conditions were trialed in "National Institute of Oncology" in a lesser frequency.

Most popular intervention types in "National Institute of Oncology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "FOLFOX4 (Oxaliplatin), Cetuximab" (1 trials) and "Glivec" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Institute of Oncology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "National Institute of Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in National Institute of Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Institute of Oncology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

National Institute of Oncology has several departments that took part in Clinical trials: "National Cancer Institute - Bratislava" - 40 trials